Skip to content
Dr Zarir F. Udwadia
  • Home
  • About
    • Achievements
    • Publications
    • Highlights
    • News & Updates
  • Gallery
  • Patient Information
    • Asthma
    • COPD/Emphysema
    • Bronchiectasis
    • Interstitial Lung Disease
    • Idiopathic Pulmonary Fibrosis
    • Sarcoidosis
    • Tuberculosis
    • Multi-drug resistant tuberculosis
    • Obstructive Sleep Apnea Syndrome
  • Contact
  • Corona Updates
Menu Close
  • Home
  • About
    • Achievements
    • Publications
    • Highlights
    • News & Updates
  • Gallery
  • Patient Information
    • Asthma
    • COPD/Emphysema
    • Bronchiectasis
    • Interstitial Lung Disease
    • Idiopathic Pulmonary Fibrosis
    • Sarcoidosis
    • Tuberculosis
    • Multi-drug resistant tuberculosis
    • Obstructive Sleep Apnea Syndrome
  • Contact
  • Corona Updates

Resistance to second-line drugs in multidrug-resistant tuberculosis.

Go to Publication

You Might Also Like

Confusing serological abnormalities in bird fancier’s lung.

June 9, 1990

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

May 18, 2014

Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians.

August 24, 2001

Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India.

March 22, 2017

Dual infection with HIV-1 and HIV-2.

June 30, 1997

Hinduja Hospital,

Mahim, Mumbai – 400016

Appointment –
022 45108181, 022 67668181

Office – 022 24447353

Breach Candy Hospital,

B. Desai Road, Mumbai – 400026

Appointment – 5-8 pm
022 23667900
022 23667995

 

Thomas Cook Building,

DN Road, Mumbai – 400001

Appointment – After 6 pm
022 22046210
022 67439337

Copyright 2026 - Dr.Zarir Udwadia